STD Rates Soar For One Surprising Age Group: The Over-55s
The latest CDC data show that chlamydia, hepatitis C, and syphilis are skyrocketing in Americans aged 55 and up. Separately, the WHO is warning about rising deaths from viral hepatitis. Also in the news: Drug-resistant Campylobacter infections rise.
Fox News:
STD Rates Skyrocket Among Americans 55 And Older: CDC
Sexually transmitted disease rates have risen sharply in a certain age group – and which group it is may surprise you. The CDC's latest statistics on STDs in the U.S. show that chlamydia, Hepatitis C, and syphilis were among the diseases that have been infecting Americans aged 55 and older at an alarming rate. The statistics, which are as recent as 2022, show how STD rates have skyrocketed since 2000. (Vacchiano, 4/9)
CIDRAP:
WHO Warns About Rising Viral Hepatitis Deaths
Global deaths from viral hepatitis are rising, despite progress with prevention and better tools for diagnosis and treatment, the World Health Organization (WHO) warned today in its annual hepatitis report, which it released at the World Hepatitis Summit. New data show that deaths rose from 1.1 million in 2019 to 1.3 million in 2022. Hepatitis is the second-leading infectious disease cause of death, with levels about the same as tuberculosis, another leading cause of infectious disease fatalities. (Schnirring, 4/9)
CIDRAP:
PAHO Issues Alert About Drug-Resistant Campylobacter Cases
The Pan American Health Organization (PAHO) last week urged member states to be on alert for cases of antibiotic-resistant Campylobacter infection in men who have sex with men (MSM) and outbreaks in high-risk populations. Citing a February outbreak of drug-resistant Campylobacter in 13 MSM in Minnesota, as well as and multiple small outbreaks in MSM in Canada dating back to 1999, PAHO encouraged member states in an information note to be vigilant in cases of MSM presenting with diarrhea with dysentery features. (Dall, 4/9)
On RSV, covid, and bird flu —
CIDRAP:
Pfizer Reports Promising Findings For RSV Vaccine In At-Risk Adults 18 To 59 Years Old
Pfizer today announced promising phase 3 clinical trial findings for a single dose of its respiratory syncytial virus (RSV) vaccine, Abrysvo, in adults ages 18 to 59 who are at increased risk of RSV infection and signaled that it would submit data to regulatory agencies as part of application for approval in that age-group. (Schnirring, 4/9)
San Francisco Chronicle:
California COVID Hospitalizations And Deaths Hit Record Lows
California is witnessing a dramatic decline in COVID-19 hospitalizations and deaths. Following a relatively subdued winter surge, the latest statistics released by the state provide a glimmer of hope as the pandemic enters its fifth year. The most recent California Department of Public Health data, published Friday, reveals that hospitalizations due to COVID-19 reached approximately 7 patients per 100,000 residents in early January, only to plummet to a historic low of 1.5 per 100,000 by March 30. (Vaziri, 4/9)
CBS News:
Bird Flu Detected In Some Birds Found In New York City Parks, Green Spaces
Bird flu has been detected in some birds found in New York City parks and green spaces. Health officials are growing more concerned about the disease and warn New Yorkers to keep their distance from wildlife. Philip Meade, a postdoctoral fellow at Icahn School of Medicine, says bird flu has been found in several geese, a peregrine falcon, a red-tailed hawk and a chicken in Marcus Garvey Park in Manhattan. (4/9)
